Citation Impact
Citing Papers
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
2014
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis
2013
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling
2016
Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan
2011
Genetic variation inCLDN1and susceptibility to hepatitis C virus infection
2009 StandoutNobel
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs
2013
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Burden of liver diseases in the world
2018 Standout
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Characterization of full‐length hepatitis C virus genotype 4 sequences
2006
Hepatitis C vaccine: supply and demand
2008
Type I interferons in infectious disease
2015 Standout
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
2014
Epidemiology and natural history of HCV infection
2013
HCV transmission in industrialized countries and resource-constrained areas
2013
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States
2006
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Global burden of liver disease: 2023 update
2023 Standout
Epidemiology of hepatitis C virus infection
2007
Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality
2009
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Acute Hepatitis C: A Systematic Review.
2008
Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C
2009
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients
2017 StandoutNobel
Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives
2018
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection
2016
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Antiviral Stilbene 1,2-Diamines Prevent Initiation of Hepatitis C Virus RNA Replication at the Outset of Infection
2011 StandoutNobel
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
The Hepatitis C Virus NS4B Protein Can trans -Complement Viral RNA Replication and Modulates Production of Infectious Virus
2008
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design
2013 StandoutNobel
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Mohamed Mostafa being referenced
Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection
2008
Analysis of IL28B Variants in an Egyptian Population Defines the 20 Kilobases Minimal Region Involved in Spontaneous Clearance of Hepatitis C Virus
2012
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections
2005
Prospective cohort study of mother‐to‐infant infection and clearance of hepatitis C in rural Egyptian villages
2009
Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C
2008
TRANSMISSION OF HEPATITIS C VIRUS BETWEEN PARENTS AND CHILDREN
2006
Towards realistic estimates of HCV incidence in E gypt
2012